Home / Infectious Disease & Vaccines
Infectious Disease & Vaccines
Available on Demand
Discover how glycoscience is transforming how scientists understand diseases and opening new doors for drug discovery.
| 4 min read
A strain of E. coli linked to Crohn’s disease produces a compound that triggers intestinal scarring, revealing a potential treatment path.
| 9 min read
New phenotypic methods can help identify the best antibiotic to treat sepsis, UTIs, and other bacterial infections.
| 3 min read
In vivo studies of the antibiotic darobactin D22 against high-priority gram-negative bacteria show promise for further drug development.
| 8 min read
Bacteria from healthy vaginas show promise in protecting women from pathogens, but advancing their development requires more funding and research.
| 5 min read
A compound that inhibits replication of the dengue virus in mammals was similarly effective in mosquitoes consuming it via blood, reducing transmissibility.
| 3 min read
Sulopenem becomes the first oral penem antibiotic approved in the United States, expanding non-IV treatment options for UTIs.
| 4 min read
In some kids, an RSV infection is mild, while others are hospitalized. Natural killer cells might be the reason why.
| 4 min read
Structural analysis of the herpes simplex virus polymerase revealed that mutations affecting its drug binding and flexibility may drive treatment resistance.
| 3 min read
Gut microbes can protect or sensitize each other to drugs, even to non-antibiotics.
| 3 min read
A new vaccination schedule pumps up the immune response to human immunodeficiency virus, overcoming a barrier that has frustrated vaccine designers.
| 2 min read
As scientific output grows, the risk of a promising drug getting lost increases, but advances in artificial intelligence and machine learning may prevent that.
